Institutional investors hold a majority ownership of ENZN through the 61.83% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $4.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA INVESTMENT GROUP LLC Bought 302.3 Thousand shares of Enzon Pharmaceuticals Inc